Neuropathic pain therapeutics refers to a way to relieve and treat neuropathic pain through various drugs or treatments. Neuropathic pain is a chronic condition wherein pathological pain continues even after the cause of the pain is eliminated.
This report contains market size and forecasts of Neuropathic Pain Therapeutics in Global, including the following market information:
Global Neuropathic Pain Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neuropathic Pain Therapeutics market was valued at 8773.9 million in 2021 and is projected to reach US$ 10860 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anticonvulsants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neuropathic Pain Therapeutics include Pfizer, Novartis AG, AstraZeneca, GlaxoSmithKline, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Johnson & Johnson, Abbott and Endo Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuropathic Pain Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuropathic Pain Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neuropathic Pain Therapeutics Market Segment Percentages, by Type, 2021 (%)
Anticonvulsants
Antidepressants
NSAIDs
Opioids
Steroids
Others
Global Neuropathic Pain Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neuropathic Pain Therapeutics Market Segment Percentages, by Application, 2021 (%)
Diabetic Neuropathy
Chemotherapy-Induced Neuropathy Pain
Postherpetic Neuralgia
Spinal Cord Injury
Others
Global Neuropathic Pain Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neuropathic Pain Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuropathic Pain Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neuropathic Pain Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis AG
AstraZeneca
GlaxoSmithKline
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Johnson & Johnson
Abbott
Endo Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited
Merck & Co